2-AG endocannabinoid
Selected indexed studies
- The Endocannabinoid System and its Modulation by Phytocannabinoids. (Neurotherapeutics, 2015) [PMID:26271952]
- Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids. (Chem Soc Rev, 2014) [PMID:24676249]
- 1-, 2- and 3-AG as substrates of the endocannabinoid enzymes and endogenous ligands of the cannabinoid receptor 1. (Biochem Biophys Res Commun, 2022) [PMID:34995983]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- The Endocannabinoid System and its Modulation by Phytocannabinoids. (2015) pubmed
- Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids. (2014) pubmed
- 1-, 2- and 3-AG as substrates of the endocannabinoid enzymes and endogenous ligands of the cannabinoid receptor 1. (2022) pubmed
- Endocannabinoid-Based Therapies. (2022) pubmed
- Endocannabinoid overload. (2010) pubmed
- The endocannabinoid 2-AG enhances spontaneous remyelination by targeting microglia. (2019) pubmed
- A methodology for radiolabeling of the endocannabinoid 2-arachidonoylglycerol (2-AG). (2011) pubmed
- Metabolism of endocannabinoids. (2016) pubmed
- The endocannabinoid 2-arachidonoylglycerol is released and transported on demand via extracellular microvesicles. (2025) pubmed
- Endocannabinoid signaling in synaptic function. (2023) pubmed